In the STEP 1 trial, Semaglutide 2.4 mg weekly produced an average weight loss of 14.9% at 68 weeks, versus 2.4% with placebo (Wilding et al., NEJM 2021
2003 Jun;30(2):405-26, viii
Full-Dose GLP-1 Protocol GLP-1 Microdosing / Metabolic Reset Root-Cause / Functional Approach The TRU Advantage What to Expect on Your TRU Wellness Journey Invest in Your Health & Confidence: We proudly offer Patient Fi financing so you can start treatment now and pay over time with convenient monthly plans
Book your consultation today at a weight loss clinic near you in Boise, and take control of your journey toward a healthier self
After first puncture, use within 28 days under sterile conditions
Related Products Alpha-Lipoic Acid Injection Alpha lipoic acid, also known as ALA, provides the body with a powerful antioxidant that supports essential cellular functions and protects against damage